Get access to our best features
Get access to our best features
Published 2 years ago

Canada OKs Pfizer-BioNTech COVID-19 booster dose for 5 to 11 year olds

Summary by Ground News
Health Canada has authorized a booster dose of the Pfizer-BioNTech vaccine for children between five and 11 years old. The National Advisory Committee on Immunization recommends children with underlying health conditions should be offered a booster no earlier than six months after their second dose. "This booster dose provides a great option to restore protection for this age group," chief public health officer Dr. Theresa Tam says.

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 44% of the sources are Center
43% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)